Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. / Rydberg, Diana M.; Linder, Marie; Malmstrom, Rickard E.; Andersen, Morten.

In: European Journal of Clinical Pharmacology, Vol. 76, No. 6, 06.2020, p. 867-876.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rydberg, DM, Linder, M, Malmstrom, RE & Andersen, M 2020, 'Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication', European Journal of Clinical Pharmacology, vol. 76, no. 6, pp. 867-876. https://doi.org/10.1007/s00228-020-02856-6

APA

Rydberg, D. M., Linder, M., Malmstrom, R. E., & Andersen, M. (2020). Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. European Journal of Clinical Pharmacology, 76(6), 867-876. https://doi.org/10.1007/s00228-020-02856-6

Vancouver

Rydberg DM, Linder M, Malmstrom RE, Andersen M. Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. European Journal of Clinical Pharmacology. 2020 Jun;76(6):867-876. https://doi.org/10.1007/s00228-020-02856-6

Author

Rydberg, Diana M. ; Linder, Marie ; Malmstrom, Rickard E. ; Andersen, Morten. / Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. In: European Journal of Clinical Pharmacology. 2020 ; Vol. 76, No. 6. pp. 867-876.

Bibtex

@article{f1194fda6d4b4562832a6eff888317da,
title = "Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication",
keywords = "Anticoagulants, Warfarin, Women, Men, Adverse drug events, Severe bleeding, Haemorrhage, Sex differences",
author = "Rydberg, {Diana M.} and Marie Linder and Malmstrom, {Rickard E.} and Morten Andersen",
year = "2020",
month = jun,
doi = "10.1007/s00228-020-02856-6",
language = "English",
volume = "76",
pages = "867--876",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication

AU - Rydberg, Diana M.

AU - Linder, Marie

AU - Malmstrom, Rickard E.

AU - Andersen, Morten

PY - 2020/6

Y1 - 2020/6

KW - Anticoagulants

KW - Warfarin

KW - Women

KW - Men

KW - Adverse drug events

KW - Severe bleeding

KW - Haemorrhage

KW - Sex differences

U2 - 10.1007/s00228-020-02856-6

DO - 10.1007/s00228-020-02856-6

M3 - Journal article

C2 - 32222786

VL - 76

SP - 867

EP - 876

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 6

ER -

ID: 243999340